Headlands Technologies’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-828
| Closed | -$88.7K | – | 1358 |
|
|
2024
Q4 | $88.7K | Buy |
828
+18
| +2% | +$1.93K | 0.01% | 690 |
|
|
2024
Q3 | $81.1K | Buy |
810
+52
| +7% | +$5.21K | 0.01% | 715 |
|
|
2024
Q2 | $63.9K | Buy |
758
+135
| +22% | +$11.4K | 0.01% | 731 |
|
|
2024
Q1 | $45.5K | Sell |
623
-341
| -35% | -$24.9K | 0.01% | 744 |
|
|
2023
Q4 | $68.8K | Sell |
964
-409
| -30% | -$29.2K | 0.02% | 466 |
|
|
2023
Q3 | $82.3K | Sell |
1,373
-240
| -15% | -$14.4K | 0.04% | 347 |
|
|
2023
Q2 | $116K | Buy |
+1,613
| New | +$116K | 0.04% | 365 |
|